Hutchison China MeditTech Limited

Home » Hutchison China MeditTech Limited

Secondary

Hutchison China MeditTech Limited

Chi-Med is an innovative biopharmaceutical company which researches, develops, manufactures and sells pharmaceuticals and healthcare products. Its Innovation Platform, Hutchison MediPharma Limited, focuses on discovering and developing innovative therapeutics in oncology and autoimmune diseases for the global market.

Symbol

HCM

Last Closing Price
$29.08

Shares
9,000,000

Effective Date
October 26, 2017

Underwriters
BofA Merrill Lynch, Deutsche Bank

To view the prospectus for Hutchison China MeditTech Limited, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253